Drug Research Ethics Committee (in Spanish, Comité de Ética de la Investigación con medicamentos, CEIm)
It is the independent body, made up of healthcare professionals and non-healthcare members, responsible for ensuring the protection of the rights, safety and well-being of subjects participating in a clinical trial and for providing public assurance in this regard.
Its purpose is to supervise and monitor clinical trials on an ongoing basis in order to ensure that they comply with current regulations on methodological and ethical aspects.
FIVO CEIm
Management of Clinical Trial contracts
Clinical trials at the IVO
The IVO has participated in the development of most of the new cancer drugs marketed in the last 20 years and currently has one of the most clinical trials on cancer drugs in all of Spain.
